Reference Number: 22041346
Request ID:17-00107137
Date First Offered08/01/2017
Title:Next Generation Sequencing (MiSeqDx) Instrument

Agency Reference Number:17-107137
Agency:DPH - Public Health
Purchasing Agency:DPH - Public Health
Purchasing Agency SPO:Denise Hudson

Status: Closed


Description and Specifications:
The Illinois Department of Public Health is giving notice of intent to award a contract as a Sole Source to: Illumina Inc. This contract is to purchase one (1) MiSeqDx system for the Chicago lab, new born screening section for next generation sequencing (NGS) and genetic analysis of various new born baby specimens. The one time purchase of a MiSeqDx instrument includes software, installation kits and standards, installation, training and 12 months parts and labor warranty.

A hearing is scheduled for 2:00 p.m. on October 18, 2017 at the Stratton Office Building, 401 S. Spring St., Room 511, Springfield, IL 62706. Call-in information for those unable to attend in person will be provided upon request. Interested parties wishing to request a hearing or submit comments must do so in writing and submit their request to the notice contact. Request for a public hearing by an interested party or written comments shall be made by Friday, October 13, 2017, by 5:00 p.m. to:

Dianne Richman
712 Stratton Office Building
401 S. Spring Street
Springfield, Il 62706
Phone: 217-558-6897
Fax: 217-558-1399

The hearing will be cancelled unless an interested party submits written comments or makes a written request for public hearing by Friday, October 13, 2017 at 5:00 p.m. to the notice contact listed above.

If a public hearing is requested, the purchasing agency shall present testimony justifying the procurement method. Any interested party may present testimony for or against the awarding of a sole source contract. The purpose of the hearing will be to receive information from the public as to whether contract award by Sole Source is appropriate and in accordance with the Illinois Procurement Code. Formal rules of evidence will not apply. Hearings may be recorded in order to aid in the production of minutes. Parties may submit written comments in lieu of attending the hearing. Written comments will be afforded the same weight as oral comments received at hearing. After consideration of the testimony, the Chief Procurement Officer may approve the purchasing agency’s request to contract by the sole source procurement method.

NOTICE: The start and end dates of this contract will depend on actual signature dates. The dates provided below are estimated for the purpose of the Illinois Procurement Bulletin hearing notice.

Key Information

Notice Type:Sole Source
Notice Stage:
Hearing Notice of Decision Upheld

Notice Expiration Date:11/08/2017
Sole Source Only Justification:Illumina, Inc. is the sole manufacturer and vendor of the equipment MiSeqDx. It is the only vendor capable of providing trained technicians, parts or software updates for these instruments. Illumina, Inc. does not train third party vendors for these instruments.

The US Food and Drug Administration (FDA) and the Center for Disease Control and Prevention (CDC) have developed the genetic testing protocols for Illumina MiSeqDx next generation sequencer for cystic fibrosis. CDC has approved this instrument for sequencing. In addition, a database being developed by the FDA and CDC is built on data from the Illumina, Inc. MiSeqDx DNA instrument. There is no other alternate equipment or vendor that is approved by FDA or CDC.
Accordance with Admin Rule:< Item is patented or copyrighted and only available from holder of patent/copyright

Professional & Artistic:No
Small Business Set-Aside:No

Does this solicitation contain a BEP or DBE requirement?:No

Does this solicitation contain a Veteran requirement?:No

Relevant Category:Equipment

Total Amount of Award:$128,977.00 (Total Dollar Value Only/Includes Any Renewal Options)
Estimated/Actual Value Description:Actual
Length of Initial Term:12
Contract Begin Date:10/01/2017
Contract End Date:09/30/2018
Renewal Terms:0


Number of Responding Bidders:0
Number of Unsuccessful Bidders:0
Total Number Awarded:0

Listing of All Bidders/Offerors Considered But Not Selected:
Source Selection:N/A

Vendor(s) Selected for Award
Vendor NameAmount of Award BEP Goal % DBE Goal %
Illumina, Inc. $128,977.000%0%

Notice Contact
Name: Dianne Richman
Street Address:712 Stratton Office Building
401 S. Spring Street
Zip Code:62706
Phone: 217-558-6897
Fax Number:217-558-1399

Class Code

Class Codes:




To download file(s), click on filename(s) located below. Not all Notices will have files to download.

File Attachments: